T. Rowe Price Health Care ETF (TMED)
NASDAQ: TMED · Real-Time Price · USD
30.49
+0.23 (0.75%)
Feb 27, 2026, 4:00 PM EST - Market closed
0.75% (1D)
| Assets | $19.83M |
| Expense Ratio | 0.44% |
| PE Ratio | 28.90 |
| Shares Out | 650,000 |
| Dividend (ttm) | $0.16 |
| Dividend Yield | 0.53% |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Ratio | 15.32% |
| 1-Year Return | n/a |
| Volume | 6,073 |
| Open | 29.77 |
| Previous Close | 30.26 |
| Day's Range | 29.77 - 30.49 |
| 52-Week Low | 23.46 |
| 52-Week High | 31.19 |
| Beta | n/a |
| Holdings | 107 |
| Inception Date | Jun 11, 2025 |
About TMED
Fund Home PageThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The ETF currently has 19.28m in AUM and 106 holdings. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.
Asset Class Equity
Category Health
Stock Exchange NASDAQ
Ticker Symbol TMED
ETF Provider T. Rowe Price
Top 10 Holdings
45.57% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 15.05% |
| UnitedHealth Group Incorporated | UNH | 6.68% |
| Abbott Laboratories | ABT | 4.34% |
| Thermo Fisher Scientific Inc. | TMO | 4.12% |
| Gilead Sciences, Inc. | GILD | 3.49% |
| Danaher Corporation | DHR | 2.88% |
| Arcellx, Inc. | ACLX | 2.55% |
| Elanco Animal Health Incorporated | ELAN | 2.40% |
| Medtronic plc | MDT | 2.09% |
| Cytokinetics, Incorporated | CYTK | 1.98% |
News
T. Rowe Price Expands ETF Lineup With 3 Actively Managed Sector Picks Across Key Sectors
In a world where passive investing tends to dominate the headlines, T. Rowe Price is gambling on an alternative formula: sector-focused active management, and at lower costs.
9 months ago - Benzinga
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds...
9 months ago - PRNewsWire